Losses extended over recession concerns

Recession concerns sent the markets tumbling during the midday with the Dow collapsing 286 points to 16,162. Nasdaq plunged 95 points to 4,524.


On the upside


VBL Therapeutics (Nasdaq: VBLT) will provide a corporate overview and business update at the 18th Annual BIO CEO & Investor Conference on February 9, 2016.


CalAmp (Nasdaq: CAMP) offered a premium of approximately $134 million in cash to acquire LoJack (Nasdaq: LOJN).


The Female Health Co. (Nasdaq: FHCO) reported higher first quarter earnings and revenue.


On the downside


Waddell & Reed Financial (NYSE: WDR) disappointed with lower fourth quarter earnings and revenue.


Carbylan Therapeutics (Nasdaq: CBYL) reported disappointing results from a Phase III trial of Hydros-TA to treat osteoarthritis pain in the knee.


ADT (NYSE: ADT) reported lower first quarter earnings.


In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 1 on the NYSE and by more than 4 to 1 on Nasdaq. The broader S&P 500 plummeted 34 points to 1,905. Bitcoin added $2 to $376.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.